Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
Apply
IMA203 vs. Investigator's Choice
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step